Antitumor effect of acridine orange under ultrasonic irradiation in vitro

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 4179-4184

  Suzuki, Norio ^a   Okada, Kyoji ^a   Chida, Shuichi ^a   Komori, Chiyo ^b   Shimada, Yoichi ^a   Suzuki, Toshio ^b  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acridine orange; Antitumor activities; Irradiation; Ultrasound

Indexed keywords

ACRIDINE ORANGE; HISTIDINE; MANNITOL;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; SURVIVAL RATE; ULTRASOUND;

ACRIDINE ORANGE; ANIMALS; APOPTOSIS; FREE RADICAL SCAVENGERS; MALE; MICE; MICE, INBRED ICR; REACTIVE OXYGEN SPECIES; SARCOMA 180; ULTRASONIC THERAPY;

EID: 37549005084     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Suzuki T, Kamada S, Yoshida Y and Unno K: A study of sonodynamic- antitumor effect on novel sonodynamic compounds under ultrasound. Heterocycles 38: 1209-1211, 1994.
2. Abe H, Kuroki M, Tachibana K, Li T, Awathi A, Ueno A, Matsumoto H, Imakiire T, Yamauchi Y, Yamada H, Ariyoshi A and Kuroki M: Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen. Anticancer Res 22: 1575-1580, 2002.
3. Okada K, Itoi E, Miyakoshi N, Nakajima M, Suzuki T and Nishida J: Enhanced antitumor effect of ultrasound in the presence of piroxicam in a mouse air pouch model. Jpn J Cancer Res 93: 216-222, 2002.
4. Kremkau FW: Cancer therapy with ultrasound. J Clin Ultrasound 7: 287-300, 1979.
5. Pickworth MJ, Dendy PP, Twentyman PR and Leighton TG: Studies of the cavitational effects of clinical ultrasound by sonoluminescence. The effect of therapeutic ultrasound on cells in monolayer culture in a standing wave field. Phys Med Biol 34: 1553-1560, 1989.
6. Zakharov SI, Bogdanor KY and Rosenshtraukh LV: The effect of acoustic cavitation force and membrane potential of rat papillary muscle. Ultrasound Med Biol 15: 561-565, 1989.
7. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D and Mittleman A: Photoradiation therapy for treatment of malignant tumors. Cancer Res 38: 2628-2635, 1978.
8. Hayata Y, Kato H, Okitsu H, Kawaguchi K and Konaka C: Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastrointestinal tract. Semin Surg Oncol 1: 1-11, 1985.
9. McCaughan JS Jr: Overview of experiences with photodynamic therapy for malignancy in 192 patients. Photochem Photobiol 46: 903-909, 1987.
10. Hourigan AJ, Kells AF and Schwartz HS: In vitro photodynamic therapy of musculoskeletal neoplasms. J Orthop Res 11: 633-637, 1993.
11. Yumita N, Nishigaki R, Umemura K and Umemura S: Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res 80: 219-222, 1989.
12. Yumita N, Nishigaki R, Umemura K and Umemura S: Synergistic effect of ultrasound and hematoporphyrin on sarcoma 180. Jpn J Cancer Res 81: 304-308, 1990.
13. Weishaupt KR, Gomer CJ and Dougherty TJ: Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res 36: 2326-2329, 1976.
14. Rabb O: Über die Wirkung Fluoreszierenden Stoffe auf Infusorien. Ztschr Biol 39: 524-546, 1900.
15. Minami G: The cytocidal effects of photodynamic therapy with acridine orange in mouse osteosarcoma cells in vitro. J Kyoto Pref Univ Med 108: 587-602, 1999.
16. Aomori K: Experimental study on the inhibition effect for local recurrence after intralesional excision of osteosarcoma using photodynamic therapy with acridine orange. J Kyoto Pref Univ Med 108: 327-338, 1999.
17. Kusuzaki K, Minami G, Takeshita H, Murata H, Hashiguchi S, Nozaki T, Ashihara T and Hirasawa Y: Photodynamic inactivation with acridine orange on a multidrug-resistant mouse osteosarcoma cell line. Jpn J Cancer Res 91: 439-445, 2000.
18. Kusuzaki K, Murata H, Matsubara T, Miyazaki S, Okamura A, Seto M, Matsumine A, Hosoi H, Sugimoto T and Uchida A: Clinical trial of photodynamic therapy using acridine orange with/without low dose radiation as new limb salvage modality in musculoskeletal sarcomas. Anticancer Res 25: 1225-1236, 2005.
19. Lewis MR and Goland PP: In vivo staining and retardation of tumors in mice by acridine compounds. Am J Med Sci 215: 282-289, 1948.
20. Lerman LS: Structural considerations in the interaction of DNA and acridines. J Mol Biol 3: 18-30, 1961.
21. Amagasa J: Binding of acridine orange to transfer RNA and photodynamic inactivation. J Radiat Res 27: 325-338, 1986.
22. Amagasa J: Mechanisms of photodynamic inactivation of acridine orange-sensitized transfer RNA: participation of singlet oxygen and base damage leading to inactivation. J Radiat Res 27: 339-351, 1986.
23. Iwamoto Y, Yoshioka H and Yanagihara Y: Singlet oxygen-producing activity and photodynamic biological effects of acridine compounds. Chem Pharm Bull 35: 2478-2483, 1987.
24. Zelenin AV: Fluorescence microscopy of lysosomes and related structures in living cells. Nature 22: 425-426, 1966.
25. Matsubara T, Kusuzaki K, Matsumine A, Seto M, Okamura A, Miyazaki S and Uchida A: Relationship between tumor affinity of acridine orange and intratumorous pH in photodynamic therapy against malignant musculoskeletal sarcoma. J Jpn Orthop Assoc 78(4): S470, 2004.
26. Matsubara T, Kusuzaki K, Matsumine A, Seto M, Okamura A and Uchida A: Relationship between sensitivity to AO and extra-cellular pH in musculoskeletal tumors. J Jpn Orthop Assoc 78(8): S1103, 2004.
27. Shustik C, Dalton W and Gros P: P-glycoprotein-mediated multidrug resistance in tumor cells, biochemistry, clinical relevance and modulation. Mol Aspects Med 16: 1-78, 1995.
28. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493, 1992.
29. Miyoshi N, Misik V and Riesz P: Sonodynamic toxicity of gallium-porphyrin analogue ATX-70 in human leukemia cells. Radiat Res 148: 43-47, 1997.
30. Umemura S, Yumita N, Nishigaki R and Umemura K: Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 81: 962-966, 1990.
31. Umemura S, Yumita N and Nishigaki R: Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 84: 1582-1588, 1993.
32. Yumita N, Nishigaki R, Umemura K, Morse PD, Swartz HM, Cain CA and Umemura S: Sonochemical activation of hematoporphyrin: an ESR study. Radiat Res 138: 171-176, 1994.
33. Sasaki K, Yumita N, Nishigaki R, Sakata I and Nakajima S: Pharmacokinetic study of a gallium-porphyrin photo- and sonosensitizer, ATX-70, in tumor-bear mice. Jpn J Cancer Res 92: 989-995, 2001.
34. Hashiguchi S: Experimental study on anti-tumor effect of combination therapy with acridine orange and radiation on a mouse osteosarcoma cell line. J Kyoto Pref Univ Med 109: 751-761, 2000.